These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Matrix metalloproteinase interactions with collagen and elastin. Van Doren SR Matrix Biol; 2015; 44-46():224-31. PubMed ID: 25599938 [TBL] [Abstract][Full Text] [Related]
8. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors. Fields GB Methods Mol Biol; 2019; 1944():229-252. PubMed ID: 30840247 [TBL] [Abstract][Full Text] [Related]
10. Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes. Chi C; Zhang Q; Mao Y; Kou D; Qiu J; Ye J; Wang J; Wang Z; Du Y; Tian J Sci Rep; 2015 Sep; 5():14197. PubMed ID: 26395067 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients. Savinov AY; Remacle AG; Golubkov VS; Krajewska M; Kennedy S; Duffy MJ; Rozanov DV; Krajewski S; Strongin AY Cancer Res; 2006 Mar; 66(5):2716-24. PubMed ID: 16510592 [TBL] [Abstract][Full Text] [Related]
13. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene. Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429 [TBL] [Abstract][Full Text] [Related]
14. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402 [TBL] [Abstract][Full Text] [Related]
15. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates. Stawikowski MJ; Knapinska AM; Fields GB Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736 [TBL] [Abstract][Full Text] [Related]